Skip to main content
Log in

Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products

  • Original Paper
  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

Abstract

Our understanding of the pathophysiology of hematopoietic failure associated syndromes led to the developmental of potentially curative procedures for the treatment of many diseases including Severe aplastic anemia, Fanconi’s anemia, Primary immunodeficiency, Osteopetrosis, and Metabolic diseases.

Although the number of patients that were transplanted for bone marrow deficiency diseases is relatively low as compared to patients with hematological malignancies, the impact on the knowledge of hematopoiesis and transplantation biology is tremendous. Moreover, the patient’s average young age suffering from these diseases further encourage searching for curative approaches.

Lucking a fully MHC matched donor, remained a significant obstacle in stem cell transplantation for non-malignant hematological disorders. Lessons from attempts to cure aplasic anemia with bone marrow transplantation guided us to the improvement of pretransplant conditioning regimens and prevention of graft versus host reactions after transplantation.

Furthermore, in recent years optimization of disease specific protocol have been successfully designed and clinically applied.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sanders JE, Whitehead J, Storb R, et al (1986) Bone marrow transplantation experience for children with aplastic anemia. Pediatrics 77:179

    Google Scholar 

  2. Locasciulli A, Van’t Veer L, Bacigalupo A, et al (1990) Treatment with bone marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia: a report from the EBMT SAA working party. Bone Marrow Transplant 6:211

    Google Scholar 

  3. Anasetti C, Doney KC, Storb R, et al (1986) Marrow transplantation for severe aplastic anemia. Long term outcome in fifty “untransfused” patients. Ann Intern Med 104:461

    Google Scholar 

  4. Storb R, Doney KC, Thomas ED, et al (1982) Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood 59:236

    Google Scholar 

  5. Storb R, Sanders JE, Pepe M, et al (1991) Graft-versus host disease prophylaxis with methotrexate/cyclophosphamide in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts. Blood 78:1144

    Google Scholar 

  6. May WS, Sensenbrenner LL, Burns WH, et al (1993) BMT for severe aplastic anemia using cyclosporine. Bone Marrow Transplant 11:459

    Google Scholar 

  7. Feig SA, Champlin R, Arenson E, et al (1983) Improved survival following bone marrow transplantation for aplastic anemia. Br J hematol 54:509

    Google Scholar 

  8. Chaplin RE, Ho WG, Nimer SD, et al (1990) Bone marrow transplantation for severe aplastic anemia. Effect of a preparative regimen of cyclophosphamide-low dose total lymphoid irradiation and posttransplant cyclosporine-methotrexate therapy. Transplantation 49:720

    Google Scholar 

  9. Castro-Malaspina H, Childs B, Laver J, et al (1994) Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA- identical marrow transplantation for severe aplastic anemia. Int J Radiat Oncol Biol Phys 29:847

    Google Scholar 

  10. Deeg HJ, Leisenring W, Storb R, et al (1998) Long term outcome after marrow transplantation for severe aplastic anemia. Blood 91:3637

    Google Scholar 

  11. Sanders JE, Team at SMT (1991) The impact of marrow transplant preparative regimens on subsequent growth and development. Semin Hematol 28:244

    Google Scholar 

  12. Clement-de Boers A, Oostdijk W, Van Weel-Sipman MH, et al (1996) Final height and hormonal function after bone marrow transplantation in children. J Pediatr 129:544

    Google Scholar 

  13. Horstmann M, Stockschlader M, Kruger W, et al (1995) Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: preliminary results. Ann Hematol 71:77

    Google Scholar 

  14. Storb R, Etzioni R, Anasetti C, et al (1994) Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 84:941

    Google Scholar 

  15. Slavin S, Nagler A, Naprastek E, et al (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91:756

    Google Scholar 

  16. Hows JM (1991) Severe aplastic anemia: the patient without an HLA-identical sibling. Br J Haematol 77:1

    Google Scholar 

  17. D’Andrea AD, Grompe M (1997) Molecular biology of Fanconi anemia: implications for diagnosis and therapy. Blood 90:1725

    Google Scholar 

  18. Young NS, Alter BP (1994) Clinical features of Fanconi’s anemia. In: Young NS, Alter BP (eds) Aplastic anemia acquired and inherited. Saunders, Philadelphia, pp 275–309

  19. Butturini A, Gale RP, Verlander PC, et al (1994) Hematologic abnormalities in Fanconi anemia: an international Fanconi anemia registry study. Blood 84:1650

    Google Scholar 

  20. Guardiola P, Socie G, Pasquini R, et al (1998) Allogeneic stem cell transplantation for Fanconi anaemia. Severe Aplastic Anaemia Working Party of the EBMT and EUFAR. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant Suppl 2:S24

  21. Gluckman E, Devergie A, Schaison G, et al (1980) Bone marrow transplantation in Fanconi anaemia. Br J Haematol 45:557

    Google Scholar 

  22. Socie G, Gluckman E, Raynal B, et al (1993) Bone marrow transplantation for Fanconi anemia using low-dose cyclophosphamide/thoracoabdominal irradiation as conditioning regimen: chimerism study by the polymerase chain reaction. Blood 82:2249

    Google Scholar 

  23. Kapelushnik J, Or R, Slavin S, et al (1997) A fludarabine-based protocol for bone marrow transplantation in Fanconi’s anemia. Bone Marrow Transplant 20:1109

    Google Scholar 

  24. O’Reilly RJ, Dupont B, Pahwa S, et al (1997) Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. N Engl J Med 297:1311

    Google Scholar 

  25. Parkman R (1990) The biology of bone marrow transplantation for severe combined immune deficiency. Adv Immunol 49:381

    Google Scholar 

  26. Buckley RH, Schiff SE, Schiff RI, et al (1999) Hematopoietic stem cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 340:508

    Google Scholar 

  27. Fischer A, Griscelli C, Friedrich W, et al (1986) Bone marrow transplantation for immunodeficiencies and osteopetrosis: European Survey, 1968–1985. Lancet II:1080

  28. Bach FH, Albertini RJ, Joo P, et al (1968) Bone marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet II:1364

  29. Parkman R, Rappeport J, Geha R, et al (1978) Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone marrow transplantation. N Engl J Med 198:921

    Google Scholar 

  30. Ozsahin H, Le Deist F, Benkerrou M, et al (1996) Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome for a single center. J Pediatr 129:238

    Google Scholar 

  31. Sly W (1989) Carbonic anhydrase deficiency syndrome: osteopetrosis with renal tubular acidosis and cerebral calcifications. In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 2857–2866

  32. Helfrich M, Aronson D, Everts V, et al (1991) Morphologic features of bone in human osteopetrosis. Bone 12:411

    Google Scholar 

  33. Van Hul W, Bollerslev J, Gram J, et al (1997) Localization of a gene for autosomal dominant osteopetrosis (Albers-Schonberg disease) to chromosome 1p2. Am J Hum Genet 61:363

    Google Scholar 

  34. Seiff CA, Chessels JM, Levinsky R (1983) Allogenic bone-marrow transplantation in infantile malignant osteopetrosis. Lancet I:437

  35. Gerritsen EJ, Vossen JM, Loo IH, et al (1994) Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course. Pediatrics 93:247

    Google Scholar 

  36. Horton WA, Schimk RN, Lyama T (1980) Osteopetrosis: further heterogeneity. J Pediatr 97:580

    Google Scholar 

  37. Bollerslev J (1989) Autosomal dominant osteopetrosis: bone metabolism and epidemiological, clinical, and hormonal aspects. Endocr Rev 10:45

    Google Scholar 

  38. Reference deleted

  39. Heaney C, Shalev H, Elbedour K, et al (1998) Human autosomal recessive osteopetrosis maps to 11q13, a position predicted by comparative mapping of the murine osteosclerosis (oc) mutation. Hum Mol Genet 7:1407

    Google Scholar 

  40. Abinun M, Newson T, Rowe PW, et al (1990) Importance of neurological assessment before bone marrow transplantation for osteopetrosis. Arch Dis Child 80:273

    Google Scholar 

  41. Ruben JB, Morris RJ, Judisch GF (1990) Chorioretinal degeneration in infantile malignant osteopetrosis. Am J Ophthalmol 110:1

    Google Scholar 

  42. Al-Mefty O, Fox JL, Al-Rodhan N, et al (1988) Optic nerve decompression in osteopetrosis. J Neurosurg 68:80

    Google Scholar 

  43. Eapen M, Davies SM, Ramsay NKC, et al (1998) Hematopoietic stem cell transplantation for infantile osteopetrosis. Bone Marrow Transplant 22:941

    Google Scholar 

  44. Coccia PF, Krivit W, Cervenka J, et al (1980) Successful bone marrow transplantation for infantile malignant osteopetrosis. N Engl J Med 302:701

    Google Scholar 

  45. Key L, Carnes D, Cole S, et al (1984) Treatment of congenital osteopetrosis with high-dose calcitrol. N Engl J Med 310:409

    Google Scholar 

  46. Aarskog D, Asknes L, Haneberg B, et al (1979) Acute response of parathyroid hormone in congenital osteopetrosis. Acta Paediatr Scand Suppl 277:75

    Google Scholar 

  47. Key LL, Ries WL, Rodriguiz RM, et al (1992) Recombinant human interferon gamma therapy for osteopetrosis. J Pediatr 121:119

    Google Scholar 

  48. Li YP, Chen W, Liang Y, et al (1999) Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat Genet 23:447

    Google Scholar 

  49. Horwitz EM, Gordon PL, Koo WK, et al (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932

    Google Scholar 

  50. Hobbs JR, Hugh-Jones K, Barrett AJ, et al (1981) Reversal of clinical features of Hurler’s disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet II:709

  51. Peters C, Balthazor M, Shapiro EG, et al (1996) Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 87:4894

    Google Scholar 

  52. Krivit W, Lockman LA, Watkins PA, et al (1995) The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. J Inherit Metab Dis 18:398

    Google Scholar 

  53. Hoogerbrugge PM, Brouwer OF, Bordigoni P, et al (1995) Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation. Lancet 345:1398

    Google Scholar 

  54. Vellodi A, Young EP, Cooper A, et al (1997) Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres. Arch Dis Child 76:92

    Google Scholar 

  55. McKinnis EJ, Sulzbacher S, Rutledge JC, et al (1996) Bone marrow transplantation in Hunter syndrome. J Pediatr 129:145

    Google Scholar 

  56. Malm G, Ringden O, Winiarski J, et al (1996) Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation. Bone Marrow Transplant 17:1003

    Google Scholar 

  57. Vellodi A, Cragg H, Winchester B, et al (1995) Allogeneic bone marrow transplantation for fucosidosis. Bone Marrow Transplant 15:153

    Google Scholar 

  58. Ringden O, Groth CG, Erikson A, et al (1995) Ten years’ experience of bone marrow transplantation for Gaucher disease. Transplantation 59:864

    Google Scholar 

  59. Krivit W, Peters C, Shapiro EG (1999) Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol 12:167

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Reuven Or.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Or, R., Aker, M., Shapira, M.Y. et al. Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products. Springer Semin Immun 26, 133–142 (2004). https://doi.org/10.1007/s00281-004-0169-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00281-004-0169-z

Keywords

Navigation